ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 279 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $389,708 | -90.5% | 18,700 | -89.0% | 0.00% | -90.0% |
| Q2 2023 | $4,081,080 | +1663.0% | 170,400 | +1285.4% | 0.01% | +900.0% |
| Q1 2023 | $231,486 | -1.1% | 12,300 | -25.9% | 0.00% | 0.0% |
| Q2 2022 | $234,000 | -83.0% | 16,600 | -70.8% | 0.00% | -75.0% |
| Q1 2022 | $1,378,000 | -71.8% | 56,900 | -70.0% | 0.00% | -69.2% |
| Q1 2021 | $4,889,000 | -78.4% | 189,500 | -55.2% | 0.01% | -78.3% |
| Q4 2020 | $22,592,000 | -14.2% | 422,600 | -33.8% | 0.06% | -20.0% |
| Q3 2020 | $26,326,000 | +35.8% | 638,200 | +59.5% | 0.08% | +31.6% |
| Q2 2020 | $19,393,000 | +643.9% | 400,100 | +548.5% | 0.06% | +470.0% |
| Q1 2020 | $2,607,000 | -41.8% | 61,700 | -41.1% | 0.01% | 0.0% |
| Q4 2019 | $4,483,000 | +16.1% | 104,800 | -2.3% | 0.01% | +11.1% |
| Q3 2019 | $3,862,000 | +102.6% | 107,300 | +50.5% | 0.01% | +80.0% |
| Q2 2019 | $1,906,000 | -2.9% | 71,300 | -2.5% | 0.01% | 0.0% |
| Q1 2019 | $1,963,000 | +122.8% | 73,100 | +34.1% | 0.01% | +150.0% |
| Q4 2018 | $881,000 | – | 54,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| March Altus Capital Management LP | 82,723 | $2,685,000 | 20.75% |
| HWG Holdings LP | 289,380 | $9,393,000 | 8.72% |
| Baker Brothers Advisors | 24,516,738 | $795,813,000 | 8.34% |
| HARVEY CAPITAL MANAGEMENT INC | 352,200 | $11,432,000 | 5.73% |
| Belmont Global Advisors, Inc. | 150,000 | $4,869,000 | 4.67% |
| Palo Alto Investors LP | 1,437,730 | $46,669,000 | 3.52% |
| Avoro Capital Advisors LLC | 329,500 | $10,696,000 | 2.38% |
| GARRISON BRADFORD & ASSOCIATES INC | 70,100 | $2,275,000 | 2.23% |
| WEATHERBIE CAPITAL, LLC | 401,642 | $13,037,000 | 1.85% |
| ACUTA CAPITAL PARTNERS, LLC | 85,999 | $2,792,000 | 1.34% |